Helping kids with severe obesity reduce heart risks
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether semaglutide can lower heart disease risks in children with extreme obesity. It aims to improve weight and heart health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be seen at the UK Pediatric High BMI Clinic.
- You must have Class 2 or 3 obesity (severe obesity).
- You must qualify for semaglutide treatment for weight loss.
- You cannot be taking any other weight-loss or blood pressure medicines.
- You cannot have certain health problems like kidney or liver disease.
- You cannot be pregnant, or have a history of a rare thyroid cancer in your family.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether weight loss from a medication can improve how you feel, move, and how well your heart works. It's for people who have both obesity and heart failure with reduced pumping strength.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
This study tests a medication called semaglutide (a once-a-week injection) to help teenagers with autism who have obesity lose weight and improve their body composition. It compares their results to a group of similar teens who didn't take the drug.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
Hear when a new Obese Adolescents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.